The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Prevalence of and Risk Factors for Diabetic Macular Edema in the United States
Open accessAbstract
IMPORTANCE: Diabetic macular edema (DME) is a leading cause of vision loss in persons with diabetes mellitus. Although there are national estimates for the prevalence of diabetic retinopathy and its risk factors among persons with diabetes, to our knowledge, no comparable estimates are available for DME specifically. OBJECTIVES: To estimate the prevalence of DME in the US population and to identify associated risk factors. DESIGN, SETTING, AND PARTICIPANTS: A cross-sectional analysis of 1038 participants aged 40 years or older with diabetes and valid fundus photographs in the 2005 to 2008 National Health and Nutrition Examination Survey. MAIN OUTCOMES AND MEASURES: The overall prevalence of DME and its prevalence according to age, race/ethnicity, and sex. RESULTS: Of the 1038 persons with diabetes analyzed for this study, 55 had DME, for an overall weighted prevalence of 3.8% (95% CI, 2.7%-4.9%) or approximately 746, 000 persons in the US 2010 population aged 40 years or older. We identified no differences in the prevalence of DME by age or sex. Multivariable logistic regression analysis showed that the odds of having DME were higher for non-Hispanic blacks than for non-Hispanic whites (odds ratio [OR], 2.64; 95% CI, 1.19-5.84; P = .02). Elevated levels of glycosylated hemoglobin A1c (OR, 1.47; 95% CI, 1.26-1.71 for each 1%; P < .001) and longer duration of diabetes (OR, 8.51; 95% CI, 3.70-19.54 for ≥ 10 vs <10 years; P < .001) were also associated with DME prevalence. CONCLUSIONS AND RELEVANCE: These results suggest a greater burden of DME among non-Hispanic blacks, individuals with high levels of hemoglobin A1c, and those with longer duration of diabetes. Given recent treatment advances in reducing vision loss and preserving vision in persons with DME, it is imperative that all persons with diabetes receive early screening; this recommendation is even more important for those at higher risk for DME.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“For example, African-American patients are three times more likely to present with diabetic macular edema (DME), 1.6 times more likely to present with vision-threatening diabetic retinopathy, and 4 times more likely to present with vision loss as compared to non-Hispanic Whites9–12.”
From Autonomous AI-assisted diabetic retinopathy screening at primary care is associated with increased presentation to eye care by at risk patients (2026) · cites this paper as [10]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“For example, African-American patients are three times more likely to present with diabetic macular edema (DME), 1.6 times more likely to present with vision-threatening diabetic retinopathy, and 4 times more likely to present with vision loss as compared to non-Hispanic Whites9–12.”
From Autonomous AI-assisted diabetic retinopathy screening at primary care is associated with increased presentation to eye care by at risk patients (2026) · cites this paper as [10]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“For example, African-American patients are three times more likely to present with diabetic macular edema (DME), 1.6 times more likely to present with vision-threatening diabetic retinopathy, and 4 times more likely to present with vision loss as compared to non-Hispanic Whites9–12.”
From Autonomous AI-assisted diabetic retinopathy screening at primary care is associated with increased presentation to eye care by at risk patients (2026) · cites this paper as [10]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global prevalence and major risk factors of diabetic retinopathy
Yau, J. W. Y., Rogers, S. L., Kawasaki, R., Lamoureux, E. L., Kowalski, J. W., Bek, T., Chen, S.-J., Dekker, J. M., Fletcher, A., Grauslund, J., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1909 · Cited by 4,985
Self-citationGlobal data on visual impairment in the year 2002.
(2004) · Europe PMC (PubMed Central) · Cited by 4,157
Danaei, G., Finucane, M. M., Lu, Y., Singh, G. M., Cowan, M. J., Paciorek, C. J., Lin, J. K., Farzadfar, F., Khang, Y.-H., Stevens, G. A., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60679-x · Cited by 3,568
The Wisconsin Epidemiologic Study of Diabetic Retinopathy
Klein, R. (1984) · Archives of Ophthalmology · doi:10.1001/archopht.1984.01040030398010 · Cited by 1,909
Ranibizumab for Diabetic Macular Edema
Nguyen, Q. D., Brown, D. M., Marcus, D. M., Boyer, D. S., Patel, S. S., Feiner, L., Gibson, A., Sy, J. P., Rundle, A. C., Hopkins, J. J., et al. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2011.12.039 · Cited by 1,625
The Wisconsin Epidemiologic Study of Diabetic Retinopathy
Klein, R. (1984) · Archives of Ophthalmology · doi:10.1001/archopht.1984.01040030405011 · Cited by 1,482
Klein, R., Klein, R., Moss, S. E., & Linton, K. L. P. (1992) · Ophthalmology · doi:10.1016/s0161-6420(92)32011-1 · Cited by 1,382
Mitchell, P., Bandello, F. M., Schmidt-Erfurth, U. M., Lang, G. E., Massin, P., Schlingemann, R. O., Sutter, F., Simader, C., Burian, G., Gerstner, O., et al. (2011) · Ophthalmology · doi:10.1016/j.ophtha.2011.01.031 · Cited by 1,344
The Wisconsin Epidemiologic Study of Diabetic Retinopathy
Klein, R., Klein, R., Moss, S. E., Davis, M. D., & DeMets, D. L. (1987) · Ophthalmology · doi:10.1016/s0161-6420(87)33525-0 · Cited by 1,247
Prevalence of Diabetic Retinopathy in the United States, 2005-2008
Zhang, X., Saaddine, J. B., Chou, C.-F., Cotch, M. F., Cheng, Y. J., Geiss, L. S., Gregg, E. W., Albright, A. L., Klein, B. E. K., & Klein, R. (2010) · JAMA · doi:10.1001/jama.2010.1111 · Cited by 1,196
The Prevalence of Diabetic Retinopathy Among Adults in the United States
Kempen, J. H., O'Colmain, B. J., Leske, M. C., Sm, H., Klein, R., Moss, S. E., Taylor, H. R., & Hamman, R. F. (2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.4.552 · Cited by 1,168
The Wisconsin Epidemiologic Study of Diabetic Retinopathy
Klein, R., Klein, R., Moss, S. E., Davis, M. D., & DeMets, D. L. (1984) · Ophthalmology · doi:10.1016/s0161-6420(84)34102-1 · Cited by 977
Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study
Currie, C. J., Peters, J. R., Tynan, A., Evans, M., Heine, R. J., Bracco, O. L., Zagar, T., & Poole, C. D. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61969-3 · Cited by 874
Diabetic Retinopathy in a Multi-ethnic Cohort in the United States
Wong, T. Y., Klein, R., Islam, A. F. M., Cotch, M. F., Folsom, A. R., Klein, B. E. K., Sharrett, A. R., & Shea, S. (2006) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2005.08.063 · Cited by 690
Cowie, C. C., Rust, K. F., Byrd-Holt, D. D., Gregg, E. W., Ford, E. S., Geiss, L. S., Bainbridge, K. E., & Fradkin, J. E. (2010) · Diabetes Care · doi:10.2337/dc09-1524 · Cited by 689
Klein, R., Knudtson, M. D., Lee, K. E., Gangnon, R. E., & Klein, R. (2009) · Ophthalmology · doi:10.1016/j.ophtha.2008.10.016 · Cited by 413
Harris, M. I., Klein, R., Cowie, C. C., Rowland, M., & Byrd-Holt, D. D. (1998) · Diabetes Care · doi:10.2337/diacare.21.8.1230 · Cited by 400
One-Year Outcomes of the DA VINCI Study of VEGF Trap-Eye in Eyes with Diabetic Macular Edema
Diana, V., Nguyen, Q. D., Boyer, D. S., Schmidt-Erfurth, U. M., Brown, D. M., Vitti, R., Berliner, A. J., Gao, B., Zeitz, O., Rückert, R., et al. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2012.02.010 · Cited by 389
Zhang, Y., Hu, G., Yuan, Z., & Chen, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042551 · Cited by 228
Prevalence of diabetic retinopathy in adult Latinos
Varma, R., Torres, M., Peña, F. Y., Klein, R., & Azen, S. P. (2004) · Ophthalmology · doi:10.1016/j.ophtha.2004.03.002 · Cited by 227
Self-citationThe Prevalence of Diabetic Retinopathy Among Adult Type1 Diabetic Persons in the United States
Roy, M. S. (2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.4.546 · Cited by 191
M�hlhauser, I., Sawicki, P. T., & Berger, M. (1986) · Diabetologia · doi:10.1007/bf00453501 · Cited by 168
The Wisconsin Epidemiologic Study of Diabetic Retinopathy-Reply
Klein, R. (1995) · Archives of Ophthalmology · doi:10.1001/archopht.1995.01100060024016 · Cited by 155
Vision-related quality of life in patients with diabetic macular oedema
Hariprasad, S. M., Mieler, W. F., Grassi, M. A., Green, J. L., Jäger, R., & Miller, L. C. (2007) · British Journal of Ophthalmology · doi:10.1136/bjo.2007.122416 · Cited by 133
Cigarette Smoking and Ten-year Progression of Diabetic Retinopathy
Moss, S. E., Klein, R., & Klein, B. E. K. (1996) · Ophthalmology · doi:10.1016/s0161-6420(96)30486-7 · Cited by 131
Biologic Risk Factors Associated with Diabetic Retinopathy
Varma, R., Macias, G. L., Torres, M., Klein, R., Peña, F. Y., & Azen, S. P. (2007) · Ophthalmology · doi:10.1016/j.ophtha.2006.10.023 · Cited by 129
Self-citationHamman, R. F., Mayer, E. J., Moo-Young, G. A., Hildebrandt, W., Marshall, J. A., & Baxter, J. (1989) · Diabetes · doi:10.2337/diab.38.10.1231 · Cited by 129
Cigarette Smoking and Diabetic Retinopathy
Paetkau, M. E., Boyd, T. A. S., Winship, B., & Grace, M. (1977) · Diabetes · doi:10.2337/diab.26.1.46 · Cited by 109
West, S. K., Muñoz, B. E., Klein, R., Broman, A. T., Sánchez, R., Rodriguez, J., & Snyder, R. W. (2002) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(02)01595-7 · Cited by 101
Association of Cigarette Smoking With Diabetic Retinopathy
Moss, S. E., Klein, R., & Klein, B. E. K. (1991) · Diabetes Care · doi:10.2337/diacare.14.2.119 · Cited by 91
Nepomuceno, A. B., Takaki, É., Almeida, F. P. P., Peroni, R., Cardillo, J. A., Siqueira, R. C., Scott, I. U., Messias, A. M. V., & Jorge, R. (2013) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2013.04.026 · Cited by 83
IS CIGARETTE SMOKING ASSOCIATED WITH DIABETIC RETINOPATHY?1
Klein, R., Klein, R., & Davis, M. D. (1983) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113630 · Cited by 82
Age-related differences in glycaemic control in diabetes
Selvin, E., & Parrinello, C. M. (2013) · Diabetologia · doi:10.1007/s00125-013-3078-7 · Cited by 75
Self-citationImpact of Diabetic Retinopathy on Vision-Specific Function
Lamoureux, E. L., Tai, E. S., Thumboo, J., Kawasaki, R., Saw, S., Mitchell, P. L. R., & Wong, T. Y. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2009.09.035 · Cited by 72
Emanuele, N., MORITZ, T. E., Klein, R., Davis, M. D., Glander, K. E., Khanna, A., Thottapurathu, L., Bahn, G., Duckworth, W. C., & Abraira, C. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.08.001 · Cited by 49
Solaiman, K. A. M., Diab, M. M. A. E., & Dabour, S. A. (2013) · Retina · doi:10.1097/iae.0b013e318285c99d · Cited by 37
Walker, J. M., Cove, D. H., Beevers, D. G., Dodson, P. M., Leatherdale, B. A., Fletcher, R. F., & Wright, A. D. (1985) · PubMed · Cited by 23
Research works printed but not linked: 1
- [14]Regeneron Pharmaceuticals Inc Regeneron and Bayer report positive one-year results from two phase 3 trials of EYLEA® (aflibercept) injection for the treatment of diabetic macular edema [press release] 2013 8 6 Regeneron Pharmaceuticals Inc Accessed October 8, 2013 website. http://investor.regeneron.com/releasedetail.cfm?ReleaseID=782911.
Cited by
Sorted by citations
Identifying Medical Diagnoses and Treatable Diseases by Image-Based Deep Learning
Kermany, D. S., Goldbaum, M., Cai, W., Valentim, C. C. S., Liang, H., Baxter, S. L., McKeown, A., Yang, G., Wu, X., Yan, F., et al. (2018) · Cell · doi:10.1016/j.cell.2018.02.010 · Cited by 4,842
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
The Diabetic Retinopathy Clinical Research Network (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1414264 · Cited by 1,651
Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss
Lee, R. Y., Wong, T. Y., & Sabanayagam, C. (2015) · Eye and Vision · doi:10.1186/s40662-015-0026-2 · Cited by 1,628
“Varma (2014) [215] Population United States of America Unspecified 3.”
BackgroundWong, T. Y., Cheung, C. M. G., Larsen, M., Sharma, S., & Simó, R. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.12 · Cited by 1,252
Diabetic Retinopathy Preferred Practice Pattern®
Flaxel, C. J., Adelman, R. A., Bailey, S. T., Fawzi, A. A., Lim, J. I., Vemulakonda, G. A., & Ying, G. (2019) · Ophthalmology · doi:10.1016/j.ophtha.2019.09.025 · Cited by 777
Metadata
- Authors
- Varma, R., Bressler, N. M., Doan, Q. V., Gleeson, M., Danese, M., Bower, J. K., Selvin, E., Dolan, C., Fine, J., Colman, S., & Turpcu, A.
- Affiliations
- University of Southern California (US)
- Johns Hopkins University (US)
- Outcomes Insights, Inc, Westlake Village, California
- The Ohio State University (US)
- Genentech (US)
- Corresponding author
- Varma, Rohit
- ORCID
- Venue
- JAMA Ophthalmology
- Publisher
- American Medical Association (AMA)
- Published
- 2014-11-01
- Volume
- 132
- Issue
- 11
- Pages
- 1334
- ISSN
- 2168-6165 (ISSN-L)
- PMC
- PMC4576994
- OpenAlex
- W2075206985
- Cited by
- 423
- References
- 38
- Citations by year
- 2026: 26 · 2025: 38 · 2024: 38 · 2023: 38 · 2022: 62 · 2021: 31 · 2020: 42 · 2019: 28 · 2018: 26 · 2017: 29 · 2016: 32 · 2015: 30 · 2014: 2
- FWCI
- 29.07
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- JAMA Ophthalmology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Heart, Lung, and Blood Institute (T32HL007024)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- diabetic macular edema, prevalence, risk factors, diabetes mellitus, racial disparities, non-Hispanic blacks, HbA1c, diabetes duration, vision loss, diabetic retinopathy, vision screening
- MeSH terms
- Adult, Aged, Blood Glucose, Cross-Sectional Studies, Diabetic Retinopathy, Ethnicity, Female, Health Surveys, Glycated Hemoglobin, Humans, Macular Edema, Male, Middle Aged, Nutrition Surveys, Risk Factors, United States, Prevalence, Age Distribution, Sex Distribution
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
